SCHEDULE: Discovery Capital Exits OneMedNet Stake

Sentiment:

Beneficial Ownership Amendment 14 November 2025 5:27 PM

Discovery Capital Management and affiliates have reported a complete divestment of their beneficial ownership in OneMedNet Corporation.

Worse than expectedThe reporting persons, who previously held 2,301,791 shares, have reduced their beneficial ownership to 0.0% of OneMedNet Corporation's common stock. This indicates a complete exit by a significant institutional investor group, which is generally viewed negatively by the market.

Summary

Discovery Capital Management, LLC, Robert K. Citrone, and Discovery Global Opportunity Master Fund, Ltd. (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G.
The filing indicates that as of September 30, 2025, the Reporting Persons beneficially own 0.0% of OneMedNet Corporation's Common Stock.
This represents a reduction from a previous holding of 2,301,791 shares by the Reporting Persons.
The amendment signifies that the Reporting Persons no longer hold a reportable beneficial ownership stake in the company.

Sentiment

Score: 2

Explanation: The complete divestment by a significant institutional investor group is a strong negative signal, indicating a loss of confidence or a strategic shift away from the company.

Negatives

A significant institutional investor group, Discovery Capital Management and its affiliates, has fully divested its entire stake in OneMedNet Corporation, reducing beneficial ownership from 2,301,791 shares to 0.0%.

Future Outlook

No forward-looking statements or guidance were provided in this filing, as it pertains solely to beneficial ownership reporting.

Industry Context

This filing reflects a specific investor's portfolio adjustment rather than a broader industry trend. The exit of a significant institutional investor could be interpreted as a re-evaluation of OneMedNet's prospects relative to other opportunities in the healthcare technology or data management sector.

Stakeholder Impact

Shareholders may perceive the complete exit of a significant institutional investor as a negative indicator, potentially leading to decreased investor confidence and downward pressure on the stock price.

Key Dates

Date	Description
09/30/2025	Date of event which required the filing of this statement, indicating the point at which beneficial ownership dropped to 0.0%.
11/14/2025	Date the Schedule 13G Amendment No. 1 was signed by Robert K. Citrone on behalf of all Reporting Persons.

Recommendation

sell

The complete divestment by a significant institutional investor group, as reported in this Schedule 13G/A, signals a loss of confidence or a strategic shift away from OneMedNet Corporation. Such a substantial exit by a sophisticated investor like Discovery Capital Management typically warrants a cautious or negative outlook on the stock, suggesting a 'sell' recommendation for investors.

Keywords

OneMedNet Corporation, Discovery Capital Management, Robert K. Citrone, Beneficial Ownership, Institutional Investor, Divestment, Schedule 13G/A, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.